Navigation Links
Harwood Feffer LLP Announces Investigation of Verenium Corporation

NEW YORK, Sept. 20, 2013 /PRNewswire/ -- Harwood Feffer LLP ( is investigating potential claims against the board of directors of Verenium Corporation ("Verenium" or the "Company") (NASDAQ: VRNM) concerning the proposed acquisition of the Company by BASF Corporation ("BASF").    

On September 20, 2013, Verenium announced that it had entered into a definitive agreement pursuant to which the Company will be acquired by BASF.  Under the terms of the agreement, Verenium shareholders will receive $4.00 per share.   

Our investigation concerns whether the Verenium board of directors is fulfilling its fiduciary duties, maximizing the value of the Company, disclosing all material benefits and costs, and obtaining full and fair consideration for Company shareholders. 

If you own Verenium shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

Benjamin I. Sachs-Michaels, Esq.
Robert I. Harwood, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400

Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website ( for more information about the firm.

Attorney Advertising © 2013 Harwood Feffer LLP.

SOURCE Harwood Feffer LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Applied Integrin Sciences, Inc. Announces Exceptional Results In Ovarian Cancer Study
2. BioConvergence®, Contract Manufacturing Organization for the Life Sciences Industry, Announces New Board of Directors
3. Ambit Announces Participation At The BioCentury NewsMakers in the Biotech Industry Conference
4. Natural Skin Care Solution, Probiotic Action Announces the Use of Their Probiotic Cleanser As a Anti-Acne Body Wash
5. Creabilis Announces Treatment of First Patients in its Phase 2b Trial of CT327 in Pruritus in Atopic Dermatitis Patients
6. Neogen announces 1st quarter results conference call
7. Global Industry Analysts, Inc. Announces the Launch of a Major Research Program Analysing the Global Market for Circulating Tumor Cells and Cancer Stem Cells
8. The tranSMART Foundation Announces New Version of the tranSMART Open Source Data Sharing Platform for the Life Sciences Community
9. Emmaus Life Sciences Announces Closing Of $7.5 Million Private Placement
10. AEgis Technologies Announces Official Launch of ADME WorkBench Software for Pharmacokinetics Prediction
11. Probiotics for Eczema Leader Announces New Developments in Using Probiotics for Children’s Eczema Relief
Post Your Comments:
(Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that they ... Russian pharmaceutical company, to develop and commercialize nemonoxacin (Taigexyn ... , Turkey and other members ... antibiotic for the treatment of bacterial infections including those ...
(Date:1/14/2014)... CA (PRWEB) January 14, 2014 Histogen, ... the products of cells grown under simulated embryonic conditions, ... license agreement with Suneva Medical, Inc. for physician-dispensed aesthetic ... , This agreement is an amendment to ...
(Date:1/14/2014)... New York, NY (PRWEB) January 14, 2014 ... coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua is an ... products to serve the wound care market. , Free ... Alliqua was restructured with a seasoned management team and ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 iLab Solutions, the ... as the new Director of Product Strategy. In this role, ... as iLab sub-teams to guide in the development of iLab ... provides the maximum possible benefit to the scientific community by ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2
... U.S. Department of Energys Brookhaven National Laboratory have developed ... and micrometer-sized particles. The method, based on designed DNA ... to manipulate the structure and therefore the properties ... be of interest to industry. For example, such fine-tuning ...
... 12 BioReliance Corporation, a,leading contract services ... contracted with Gentronix to offer their,GreenScreen HC ... of BioReliance,s portfolio of,genotoxicity screening services. GreenScreen ... pharmaceutical companies to test for genotoxic potential,earlier ...
... Inc. (Nasdaq:,PPDI) today announced Daniel G. Darazsdi has ... position on October 1. Mr. Darazsdi, 47, ... a $34 billion diversified technology and manufacturing,leader, where ... CFO of finance,transformation and operations. Over the years ...
Cached Biology Technology:New DNA-based technique for assembly of nano- and micro-sized particles 2BioReliance Launches Next-Generation Genotoxicity Screening Service 2PPD Names Daniel Darazsdi as Chief Financial Officer 2PPD Names Daniel Darazsdi as Chief Financial Officer 3
(Date:7/9/2014)... shows that the population is 3.79 million breeding ... Adlie penguins have long been considered a key ... of climate change and fishing in the Southern ... from Stony Brook University and University of Minnesota ... monitoring of Adlie penguins across their entire breeding ...
(Date:7/9/2014)... may be on the verge of an economy driven by ... than coal and is undergoing a production boom. It has ... recent research is casting serious doubts over just how climate-friendly ... Engineering News (C&EN), the weekly news magazine of the ... senior correspondent at C&EN, explains that when burned as a ...
(Date:7/9/2014)... candidate developed by researchers at the NIH,s ... and its collaborators to treat sickle cell ... BioScience business. The drug candidate, Aes-103, is ... underlying molecular mechanism of sickle cell disease. ... activities required for regulatory approval and commercialization. ...
Breaking Biology News(10 mins):New study finds that Adélie penguin population is on the rise 2New study finds that Adélie penguin population is on the rise 3First drug candidate from NIH program acquired by biopharmaceutical company 2First drug candidate from NIH program acquired by biopharmaceutical company 3First drug candidate from NIH program acquired by biopharmaceutical company 4
... span of a common rat, the 10 to 30 year ... to East Africa, is impressive. And compared to the human ... to aging, maintaining high activity, bone health, reproductive capacity, and ... in Israel and the United States is working to uncover ...
... during pregnancy are uncommon, but the prevalence of heart disease ... more women delay pregnancy until they are older. These women, ... tend to have higher cholesterol levels and are at greater ... research has shown that the heart typically functions better during ...
... summer season is in full swing, many of us will be ... have some unwanted guests in the form of mosquitoes. Mosquitoes ... Syed, a mosquito biologist with the University of Notre Dame,s Eck ... determining how they do it. In short, it,s because of ...
Cached Biology News:Naked mole rat may hold the secret to long life 2UCLA study looks at why heart attacks cause so much more damage in late pregnancy 2Mosquitoes -- how we smell is why they bite, research shows 2
... sensitive reagent for the detection of inorganic ... of recombinant E. coli phosphate-binding protein labeled ... to changes in its environment.How it worksBinding ... rapid and tight (Kd ~ 0.1 M), ...
... Costar strip ejector is a unique product ... strips from their holder. Linkage: This CLS ... to easily match Cornings product number. If ... the old Sigma-Aldrich number (Z71,314-7) or contact ...
... hood ventilates and purifies hazardous chemical ... exhaust. Bonded charcoal filters remove most ... clearance (with access shield open) accommodates ... options include final HEPA filter, work ...
Sigmas E-TOXATE (Limulus Amebocyte Lysate) test kits are intended for the detection and semiquantitation,of endotoxins for research purposes....
Biology Products: